IMMNOV Immunovia AB (publ)
0.0711SEK-6.45%Mkt Cap: 4.57M $P/E: —1d ago
Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins a…
Industry Peers
Diagnostics & Research$250.23BUSDP/E 36.4
$155.51BUSDP/E 39.4
$61.35BUSD
$45.82BUSDP/E 38.1
$48.29BUSDP/E 33.8
$44.35BUSDP/E 54.8
$43.80BUSDP/E 33.1
$43.21BUSDP/E 111.4
$41.58BUSDP/E 37.0
$30.89BUSDP/E 34.7
$25.63BUSDP/E 24.7
$25.12BUSD
$25.03BUSDP/E 25.5
$17.56BUSDP/E 75.3
$17.32BUSDP/E 36.4
$14.84BUSD
$14.05BUSDP/E 26.2
$12.99BUSDP/E 177.2
$10.02BUSDP/E 20.0
$9.46BUSDP/E 23.2
| Headline | Source | Time |
|---|---|---|
Older | ||
Immunovia AB (LTS:0G8X) (Q2 2026) Earnings Call Highlights: Revenue Surges 300% as PancreaSure ... Immunovia AB (LTS:0G8X) reports strong commercial adoption with 27 high-risk surveillance programs using PancreaSure, while managing cash burn below guidance ahead of Medicare submission. | ||
DDI | ||